Prometheus Laboratories Overview

  • Founded
  • 1995
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 739
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $650M
Latest Deal Amount

Prometheus Laboratories General Information

Description

Manufacturer of diagnostic and therapeutic products created for providing individualized patient care. The company's novel pharmaceutical and diagnostic products focus on the treatment, diagnosis, and detection of gastrointestinal, autoimmune and inflammatory diseases and disorders assisting physicians with more targeted services, enabling doctors to optimize care for their patients.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Parent Company
Primary Office
  • 9410 Carroll Park Drive
  • San Diego, CA 92121
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prometheus Laboratories Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 30-Jun-2019 $650M 00000 Completed Generating Revenue
5. IPO 07-Sep-2011 Cancelled Generating Revenue
4. Merger/Acquisition 14-Jul-2011 00000 Completed Generating Revenue
3. Debt Refinancing 07-Jan-2010 00000 00000 Completed Generating Revenue
2. Debt - General $18M Completed Generating Revenue
1. Later Stage VC 01-Jan-2001 $18M Completed Generating Revenue
To view Prometheus Laboratories’s complete valuation and funding history, request access »

Prometheus Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of diagnostic and therapeutic products created for providing individualized patient care. The company's nov
Therapeutic Devices
San Diego, CA
739 As of 2012
00000
0000 0000-00-00
000000&0

0000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000 000000000
Emeryville, CA
0.000 0000-00-00
00000000000

00000000

o consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000000000 000000000
Palm Beach Gardens, FL
0000 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Prometheus Laboratories Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Grifols Diagnostic Solutions Corporate Backed or Acquired Emeryville, CA 00000000000
000000000 Formerly PE-Backed Palm Beach Gardens, FL 0000 00000 000000&0 00000
0000000 0000000000 Venture Capital-Backed San Mateo, CA 0 000.00 000000 - 000 000.00
00000000 Venture Capital-Backed Saint Louis, MO 00.000 000000 - 000 00.000
00000 000000000000 Formerly VC-backed Bridgewater, NJ 0000 00000 000000&0
To view Prometheus Laboratories’s complete competitors history, request access »

Prometheus Laboratories Patents

Prometheus Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018277256-A1 Methods for assessing mucosal healing in crohn's disease patients Abandoned 31-May-2017 00000000000
JP-2020523560-A Methods to assess mucosal healing in patients with crohn's disease Pending 31-May-2017 0000000000
CA-3064529-A1 Methods for assessing mucosal healing in crohn's disease patients Pending 31-May-2017 00000000000
EP-3612843-A1 Methods for assessing mucosal healing in crohn's disease patients Withdrawn 31-May-2017 00000000000
US-20200264171-A1 Methods for assessing mucosal healing in crohn's disease patients Granted 31-May-2017 G01N33/564
To view Prometheus Laboratories’s complete patent history, request access »

Prometheus Laboratories Executive Team (11)

Name Title Board Seat Contact Info
Mark McKenna Chief Executive Officer
Peter Westlake Chief Financial Officer & Vice President
You’re viewing 2 of 11 executive team members. Get the full list »

Prometheus Laboratories Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prometheus Laboratories Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Apax Partners PE/Buyout Minority 000 0000 000000 0
Apex Venture Partners Venture Capital Minority 000 0000 000000 0
Bank of America Investment Bank Minority 000 0000 000000 0
Brentwood Venture Capital Venture Capital Minority 000 0000 000000 0
Capital Resource Partners Mezzanine Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Prometheus Laboratories Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 12-Aug-2021 00000 0000 00.00 Financial Software
Rosetta Genomics 16-Apr-2009 PIPE 000 Pharmaceuticals 000000 00
To view Prometheus Laboratories’s complete investments history, request access »

Prometheus Laboratories Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 00000000 16-Apr-2009 0000 000 Completed
  • 0000000000 0000000
To view Prometheus Laboratories’s complete exits history, request access »